Real-life experience with first-line treatment with daratumumab, bortezomib, melphalan, and prednisone in patients with newly diagnosed multiple myeloma ineligible for autologous stem-cell transplantation - Domingo-González, Amalia; Alonso Fernández, Rafael; Jiménez, Ana; De Soto Álvarez, Teresa; Lerma-Verdejo, Ana; Pradillo, Virginia; Benzo Callejo, Gonzalo; Sánchez-Pina, Jose; Landete, Elena; Velasco-Valdazo, Alberto; Menéndez-Cuevas, Marina; López Riñón, Mónica María; et al. (Frontiers in Hematology, 2024)